Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. pmc.ncbi.nlm.nih.gov › articles › PMC7669498Effectiveness of Intravenous Immunoglobulin for Management of ...

   pmc.ncbi.nlm.nih.gov › articles › PMC7669498

   Administrations of intravenous immunoglobulin (IVIG), an immune-modulating blood-derived product, may be beneficial for managing neuropathic pain. Here, we review previous studies to investigate the effectiveness of IVIG in managing neuropathic pain due to various neurological disorders.

2. www.ncbi.nlm.nih.gov › pmc › articlesImmunoglobulin Use for the Management of Painful Peripheral...

   www.ncbi.nlm.nih.gov › pmc › articles

   4 Αυγ 2022 · Administration of intravenous immunoglobulin (IVIG) has been shown to have a beneficial effect on ameliorating motor symptoms and/or preventing disease progression of immune-mediated peripheral neuropathies, such as Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy [7 ...

3. www.verywellhealth.com › intravenous-immunoglobulin-ivig-therapy-8643506IVIG Therapy: How It Works and What to Expect - Verywell Health

   www.verywellhealth.com › intravenous-immunoglobulin-ivig-therapy-8643506

   • Αποθηκευμένο αντίγραφο

   21 Μαΐ 2024 · Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune system functions poorly. It is made from human blood plasma and is, therefore, known as a biologic drug product.

4. pubmed.ncbi.nlm.nih.gov › 16391402Intravenous immunoglobulin in therapy of peripheral neuropathy

   pubmed.ncbi.nlm.nih.gov › 16391402

   IVIg is used today as a first-line therapy in the treatment of Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

5. www.neurology.org › doi › 10Intravenous gammaglobulin (IVIg) for treatment of CIDP and...

   www.neurology.org › doi › 10

   24 Δεκ 2002 · Intravenous immune globulin (IVIg) is considered an effective and safe treatment for autoimmune neuropathies, especially in comparison to the alternative treatments such as corticosteroids, chemotherapy, and plasmapheresis.

6. pmc.ncbi.nlm.nih.gov › articles › PMC8457117Subcutaneous immunoglobulin treatment for chronic inflammatory...

   pmc.ncbi.nlm.nih.gov › articles › PMC8457117

   Immunoglobulin G (IgG) therapy is an established long‐term treatment in chronic inflammatory demyelinating polyneuropathy (CIDP) that is commonly administered intravenously (IVIg).